Hereditary angioedema: Optimal therapy

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 4, 2007, Pages 756-757

  Sheffer, Albert L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BERINERT P; CINRYZE; COMPLEMENT COMPONENT C1S INHIBITOR; ECALLANTIDE; FRESH FROZEN PLASMA; ICATIBANT; KALLIKREIN INHIBITOR; METHYLTESTOSTERONE; RHUCIN; SERINE PROTEINASE INHIBITOR; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; AUTOSOMAL DOMINANT INHERITANCE; BLOOD VESSEL PERMEABILITY; EDITORIAL; ENZYME SYNTHESIS; HUMAN; INCIDENCE; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS;

ANGIONEUROTIC EDEMA; COMPLEMENT C1 INACTIVATOR PROTEINS; HUMANS;

EID: 35148834176     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.010     Document Type: Editorial

References (19)

1. Davis A.E. C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 6 (1988) 595-628
2. Donaldson V.H., and Bissler J.J. C1-inhibitors and their genes: an update. J Lab Clin Med 119 (1992) 330-333
3. Landerman N.S., Webster M.E., Becker E.L., and Ratcliffe H.E. Hereditary angioneurotic edema, II: deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J Allergy 33 (1962) 330-341
4. Donaldson V.H., and Evans R.R. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C' 1-esterase. Am J Med 35 (1963) 37-44
5. Rosen F.S., Pensky J., Donaldson V., and Charache P. Hereditary angioneurotic edema: two genetic variants. Science 148 (1965) 957-958
6. Bowen T., Cicardi M., Farkas H., Bork K., Kreuz W., Zingale L., Varga L., et al. Canadian 2003 International Consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 114 (2004) 629-637
7. Davis A.E. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am 26 (2006) 633-651
8. Zuraw B.L., and Curd J.G. Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients. J Clin Invest 78 (1986) 567-575
9. Fields T., Ghebrehiwet B., and Kaplan A.P. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol 72 (1983) 54-60
10. Schapira M., Silver L.D., Scott C.F., Schmaier A.H., Prograis Jr. L.J., Curd J.G., et al. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med 308 (1983) 1050-1053
11. Nussberger J., Cugno M., Amstutz C., Cicardi M., Pellacani A., and Agostoni A. Plasma bradykinin in angio-edema. Lancet 351 (1998) 1693-1697
12. Han E.D., MacFarlane R.C., Mulligan A.N., Scafidi J., and Davis A.E. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 109 (2002) 1057-1063
13. Spaulding W.B. Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med 53 (1960) 739-745
14. Frank M.M., Sergent J.S., Kane M.A., and Alling D.W. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double-blind study. N Engl J Med 286 (1972) 808-812
15. Sheffer A.L., Austen K.F., and Rosen F.S. Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med 287 (1972) 452-454
16. Pickering R.J., Good R.A., Kelly J.R., and Gewurz H. Replacement therapy in hereditary angioedema: successful treatment of two patients with fresh frozen plasma. Lancet 1 (1969) 326-330
17. Gadek J.E., Hosea S.W., Gelfand J.A., Santaella M., Wickerhauser M., Triantaphyllopoulos D.C., et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med 301 (1980) 542-546
18. Waytes A.T., Rosen F.S., and Frank M.M. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 334 (1996) 1630-1634
19. Farkas H., Jakab L., Temesszentandrasi G., Visy B., Harmat G., Füst G., et al. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol 120 (2007) 941-947